Rani Therapeutics Holdings Inc (RANI) — Cash Flow Reinvestment Rate
Latest as of December 2025:
105.35x
Rani Therapeutics Holdings Inc (RANI) has a Cash Flow Reinvestment Rate of 105.35x as of December 2025, reinvesting $30.97 Million (capex $0.00 plus investments $-30.97 Million) from operating cash flow of $294.00K. See RANI free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
105.35x
(Capex + Investments) / Operating CF
Total Reinvested
$30.97 Million
Capex + Investments
Operating Cash Flow
$294.00K
USD
Capital Expenditures
$0.00
USD
Annual Cash Flow Reinvestment Rate for Rani Therapeutics Holdings Inc (None–None)
Year-by-year capital reinvestment analysis for Rani Therapeutics Holdings Inc. See how financially flexible is Rani Therapeutics Holdings Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow